Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.

Abstract

Weight loss in patients with amyotrophic lateral sclerosis (ALS) is associated with faster disease progression and shorter survival. Decreased hypothalamic volume is proposed to contribute to weight loss due to loss of appetite and/or hypermetabolism. We aimed to investigate the relationship between hypothalamic volume and body mass index (BMI) in ALS and Alzheimer's disease (AD), and the associations of hypothalamic volume with weight loss, appetite, metabolism and survival in patients with ALS. We compared hypothalamic volumes from magnetic resonance imaging scans with BMI for patients with ALS (n=42), patients with AD (n=167) and non-neurodegenerative disease controls (n=527). Hypothalamic volumes from patients with ALS were correlated with measures of appetite and metabolism, and change in anthropomorphic measures and disease outcomes. Lower hypothalamic volume was associated with lower and higher BMI in ALS (quadratic association; probability of direction=0.96). This was not observed in AD patients or controls. Hypothalamic volume was not associated with loss of appetite (p=0.58) or hypermetabolism (p=0.49). Patients with lower BMI and lower hypothalamic volume tended to lose weight (p=0.08) and fat mass (p=0.06) over the course of their disease, and presented with an increased risk of earlier death (hazard ratio [HR]3.16, p=0.03). Lower hypothalamic volume alone trended for greater risk of earlier death (HR2.61, p=0.07). These observations suggest that lower hypothalamic volume in ALS contributes to positive and negative energy balance, and is not universally associated with loss of appetite or hypermetabolism. Critically, lower hypothalamic volume with lower BMI was associated with weight loss and earlier death.